CCDD Discussion, January 23rd noon ET

Thankyou to those who participated in the discussions from the January 23rd call.

The notes from the call can be found here 20190123 CCDD Meeting Notes

If anyone finds any inconsistency in the notes or has any questions, please reach out to This email address is being protected from spambots. You need JavaScript enabled to view it.
Regards
Beverly and the CCDD team

Hello
please find the agenda with links to the supporting material.
We look forward to your input in the discussions.

Beverly and CCDD team.

20190123 - CCDD Meeting Agenda

Hello
Here is a list of the topics for discussion on the Jan 23rd call. The supporting material will be posted a week before the call.
1. Liposomal products
• How to clearly distinguish between medicinal products that are formulated using liposomes from those that are not.
• To confirm the recommendation provided in the December call.
2. Vitamins
• Discuss the analysis of how to consistently describe vitamins.
3. Hyacine & scopolamine
• Hyoscine and scopolamine are synonyms but the DPD uses both. A discussion will include options for how CCDD should use one name to describe the moiety substance in both the TM and the NTPs.
4. Discuss an update on CCDD scope with a focus on hospital drug products.

thankyou
Beverly

Please join this call to participate in a couple of important topics related to CCDD vitamin and liposomal product content.

The details for the meeting event can be found here infocentral.infoway-inforoute.ca/en/?option=com_jevents&task=icalrepeat.detail&evid=2829&Itemid=1741&year=2019&month=01&day=23&title=ccdd-medication-management-discussion&uid=9b29ca16a3a2c6af2fbd945335b6065d

The agenda will follow at least a week prior to the call.
thankyou
Beverly